Saeed et al. identified RACGAP1 and MKI67 as potential prognostic biomarkers for HBV/HCV-associated HCC mediated by lactylation, thus pioneering new avenues for immune-targeted therapies (Saeed et al., 2025). The gene discussed is RACGAP1; the disease is hepatocellular carcinoma.